Acne Procedural denied due to quantity / dose limits by Humana?

Humana's specific coverage criteria for acne procedural are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Limits the Number of Acne Procedures — and Why You Can Appeal

Quantity-limit denials for acne-related procedures (such as office-based comedone extraction, chemical peels, intralesional corticosteroid injections, or photodynamic therapy) are common. Humana sets per-period frequency caps based on its internal medical-policy guidelines. A denial does not mean your treatment was inappropriate — it means the number of sessions requested exceeded the plan's preset threshold, which may not reflect your individual clinical picture.

## Why This Denial Is Appealable

Quantity limits must be clinically justified for your specific case. Under the ACA §2719 framework and ERISA §503, you have the right to a full-and-fair internal review followed, if needed, by an independent external review. Insurers cannot simply apply a numeric cap without considering whether your medical circumstances warrant additional treatment. If your dermatologist documents a clear clinical reason — for example, treatment-resistant inflammatory acne, scarring risk, or inadequate response to prior sessions — that documentation can directly challenge the limit's application to your case.

## Your Appeal Timeline

• Internal appeal deadline: Typically 180 days from the denial notice (confirm the exact date on your Explanation of Benefits).
• External review: Available after exhausting internal appeals, generally within four months of the final internal denial. An expedited track is available if your condition is urgent.
• Expedited internal appeal: Request this if waiting for standard review would seriously jeopardize your health.

## Documentation to Gather

1. Diagnosis confirmation: Chart notes establishing acne severity, subtype (comedonal, inflammatory, nodular, cystic), and duration. 2. Treatment history with dates and outcomes: A log of every prior treatment attempted, how long each was tried, and why it was insufficient or discontinued. 3. Clinical severity in the chart: Photographs taken at office visits, lesion counts, or validated severity scales your provider uses — whatever is already in the record. 4. Prescriber medical-necessity letter: A signed letter from your dermatologist explaining why the quantity requested is medically necessary for your case, referencing the specific clinical features that distinguish your situation from a routine presentation. 5. Applicable guideline reference: Ask your provider to note alignment with the relevant professional-society guidelines (e.g., AAD guidelines for acne management) without citing specific numbers — just the organization's recommendation that individualized treatment frequency is appropriate.

## Criteria-Mapping Structure

Obtain Humana's published medical policy for the specific procedure code being denied. Then, for each stated quantity-limit criterion, map it to a concrete fact from the chart:

| Policy Requirement | Supporting Chart Fact | |---|---| | Diagnosis confirmed | [Date of diagnosis, chart note reference] | | Prior treatments attempted | [List treatments, dates, outcomes] | | Clinical indication for additional sessions | [Provider's documented rationale] | | Frequency requested is consistent with clinical need | [Prescriber letter] |

An appeal that walks through each criterion with specific chart evidence — rather than a general disagreement — is far more likely to succeed.